Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-'alfa' levels in rat diaphragm muscle (2006)

  • Authors:
  • USP affiliated authors: MARTINS, RODRIGO ALVARO BRANDÃO LOPES - ICB
  • USP Schools: ICB
  • DOI: 10.1007/s10103-006-0405-y
  • Subjects: FARMACOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10103-006-0405-y (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Lasers in Medical Science

    ISSN: 0268-8921

    Citescore - 2017: 2.14

    SJR - 2017: 0.713

    SNIP - 2017: 1.067


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100019179PC-ICB BMF SEP 2006
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      AIMBIRE, F.; LOPES-MARTINS, Rodrigo Alvaro Brandão; CASTRO-FARIA-NETO, H. C.; et al. Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-'alfa' levels in rat diaphragm muscle. Laser in Medical Science, London, v. 21, n. 4, p. 238-244, 2006. DOI: 10.1007/s10103-006-0405-y.
    • APA

      Aimbire, F., Lopes-Martins, R. A. B., Castro-Faria-Neto, H. C., Albertini, R., Chavantes, M. C., Pacheco, M. T. T., et al. (2006). Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-'alfa' levels in rat diaphragm muscle. Laser in Medical Science, 21( 4), 238-244. doi:10.1007/s10103-006-0405-y
    • NLM

      Aimbire F, Lopes-Martins RAB, Castro-Faria-Neto HC, Albertini R, Chavantes MC, Pacheco MTT, Leonardo PSLM, Iversen VV, Bjordal JM. Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-'alfa' levels in rat diaphragm muscle. Laser in Medical Science. 2006 ; 21( 4): 238-244.
    • Vancouver

      Aimbire F, Lopes-Martins RAB, Castro-Faria-Neto HC, Albertini R, Chavantes MC, Pacheco MTT, Leonardo PSLM, Iversen VV, Bjordal JM. Low-level laser therapy can reduce lipopolysaccharide-induced contractile force dysfunction and TNF-'alfa' levels in rat diaphragm muscle. Laser in Medical Science. 2006 ; 21( 4): 238-244.

    Referências citadas na obra
    Fahal IH, Bell GM, Bone JM, Edwards RH (1997) Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant 12:119–127
    American Thoracic Society and European Respiratory Society (1999) Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:S1–S40 (Suppl)
    Claesson BE, Svensson NG, Gotthardsson L, Garden B (1992) A food borne outbreak of group A streptococcal disease at a birthday party. Scan J Infect Dis 24:577–586
    Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, Coats AJ (1997) Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30:1758–1764
    Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen W, Shou Z, Liu P (1999) Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99:1492–1498
    Wilcox P, Osborne S, Bressler B (1992) Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. Am Rev Respir Dis 146:462–466
    Di Francia M, Barbier D, Mege JL, Orehek J (1994) Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453–1455
    Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe heart failure. N Engl J Med 223:236–241
    Spooner CE, Markowitz NP, Saravolatz LD (1992) The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 62:S11–S17
    Dorge SE, Roux-Lombard P, Dayer JM, Koch KM, Frei U, Lonnemann G (1994) Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 58:1000–1008
    Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD (1998) Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32:393–397
    St. Pierre BA, Kasper CE, Lindsey AM (1992) Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. Oncol Nurs Forum 19:419–425
    Roubenoff R (1995) Tumor necrosis factor and AIDS. Am J Clin Nutr 61:161–162
    Nakashima J, Tachibana M, Ueno M, Baba S, Tazaki H (1995) Tumor necrosis factor and coagulopathy in patient with prostate cancer. Cancer Res 55:4881–4885
    Vreugdenhil G, Lowenberg B, VanEijk HG, Swaak JG (1992) Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Investig 22:488–493
    Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J (1994) Tumor necrosis alpha decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med 150:1368–1373
    Li X, Moody MR, Engel D, Walker S, Clubb FJ, Sivasubramanian N, Mann dL, Reid MB (2000) Cardiac-specific overexpression of TNF-α causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102:1690–1696
    Alloatti G, Penna C, Mariano F, Camussi G (2000) Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-α. Am J Physiol Regul Integr Comp Physiol 279:R2156–R2163
    Tavares de Lima W, Steil AA, Russo M, Starobinas N, Teixeira CFP, Jancar S (1998) Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur J Pharmacol 358:69–75
    Jansen M, Hendriks T, Knapen M, van Kempen L, van der Meer J, Goris R (1998) Chlorpromazine down-regulates tumor necrosis factor and attenuates experimental multiple organ dysfunction syndrome in mice. Crit Care Med 26(7):1244–1250
    Gadina M, Bertini M, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxin shock. J Exp Med 173:1305–1310
    Bertini R, Mengozzi M, Bianchi M (1991) Chlorpromazine protection against interleukin-1 and tumor necrosis factor- mediated activities in vivo. Int J Immunopharmacol 13:1085–1090
    Pilkington CA, Wedderburn IR (2005) Pediatric idiopathic inflammatory disease: recognition and management. Drugs 65(10):1355–1365
    Brosseau L, Wells G, Marchand S, Gaboury I, Stokes B, Morin M, Casimiro L, Yonge K, Tugwell P (2005) Randomized controlled trial on low level laser therapy (LLLT) in the treatment of osteoarthritis (OA) of the hand. Lasers Surg Med 36(3):210–219
    Gur A, Cosut A, Sarac AJ (2003) Efficacy of different therapy regimes of low-power laser in painful osteoarthritis of the knee: a double-blind and randomized-controlled trial. Lasers Surg Med 33:330–338
    Bjordal JM, Johnson MI, Iversen VV, Aimbire F, Lopes-Martins RAB (2005) Low Level Laser Therapy (LLLT) in acute pain. A systematic review of possible mechanisms of low-level laser therapy action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg 24(1):160–170
    Brosseau L, Welch V, Wells G, deBie R, Gam A, Harman K (2005) Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 4. DOI 10.1002/14651858.CD002049
    Bouma MG, Buurman WA, van den Wildenberg FA (1996) Low energy laser irradiation fails to modulate the inflammatory function of human monocytes and endothelial cells. Lasers Med Surg 19:207–215
    Shimizu N, Yamagushi M, Goseki T, Shibata Y, Takiguchi H, Iwasawa T (1995) Inhibition of prostaglandin E2 and interleukin-1β production by low power laser irradiation in stretched human periodontal ligament cells. J Dent Res 74:1382–1388
    Sakurai Y, Yamagushi M, Abiko Y (2000) Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 and cyclooxygenase-2 in human gingival fibroblast. Eur J Oral Sci 108(1):29–34
    Campana V, Moya M, Gavotto A, Soriano F, Juri H, Spitale L (1999) The relative effects of HeNe laser and meloxicam on experimentally induced inflammation. Laser Ther 11(1):36–41
    Albertini R, Aimbire FS, Correa FI, Ribeiro W, Cogo JC, Antunes E, Teixeira SA, De Nucci G, Castro-Faria-Neto HC, Zângaro RA, Lopes-Martins RAB (2004) Effects of different protocols doses of low power laser gallium–aluminum–arsenate (Ga–Al–As) laser radiation (650 nm) on carrageenan induced paw oedema. J Photochem Photobiol B 72(2–3):101–107
    Aimbire F, Albertini R, Leonardo PSLM, Castro Faria Neto HC, Iversen VV, Lopes-Martins RAB, Bjordal JM (2006) Low level laser therapy induces dose-dependent reduction of TNFα-levels in acute inflammation. Photomed Laser Surg 24:33–37
    Nicolau RA, Martinez MS, Rigau J, Tomàs J (2002) Neurotransmitter release changes induced by low power 830 nm diode laser irradiation on the neuromuscular junctions of the mouse. Lasers Surg Med 35:236–241
    Hussain SN (1998) Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179:125–134
    Braith RW, Limacher MC, Legget SH, Pollock ML (1993) Skeletal muscle strength in heart transplant recipients. J Heart Lung Transplant 12:1018–1023
    Simon AM, Zittoun R (1999) Fatigue in cancer patients. Curr Opin Oncol 11:244–249
    Cianfrocca M, Von Roenn JH (1997) Wasting and cachexia in patients with HIV. Aids Patient Care STDS 11:259–267
    Fujimura N, Sumita S, Aimono M, Masuda Y, Shichinohe Y, Narimatsu E, Namiky A (2000) Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med 162:2159–2165
    Taille C, Foresti R, Lanone S, Zedda C, Greeen C, Aubier M, Motterlini R, Boczkowski J (2001) Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med 163:753–761
    Comtois AS, Barriero E, Huang PL, Marette A, Perrault M, Hussain SNA (2001) Lipopolysaccharide-induced diaphragmatic contractile dysfunction and sarcolemmal injury in mice lacking the neuronal nitric oxide synthase. Am J Respir Crit Care Med 163:977–982
    Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634
    Reid MB, Lännergren J, Westerblad H (2002) Respiratory and limb muscle weakness induced by tumor necrosis factor-α. Am J Respir Crit Care Med 166:479–484
    Hopkins PM (1996) Human recombinant TNF-alpha affects rat diaphragm muscle in vitro. Intensive Care Med 153:1611–1615
    Wilcox P, Milliken C, Bressler B (1996) High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor. Am J Respir Crit Care Med 153:1611–1615
    Diaz PT, Julian MW, Wewers MD, Clanton TL (1993) Tumor necrosis factor and endotoxin do not directly affect in vitro diaphragm function. Am Rev Respir Dis 148:281–287
    Yokohama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92:2302–2312
    Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT (1986) Cachexia/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 164:1368–1373
    Kandolf-Sekulovic L, Kataranovski M, Pavlovic MD (2003) Immunomodulatory effects of low-intensity near-infrared laser irradiation on contact hypersensitivity reaction. Photodermaltol Photoimmunol Photomed 19(4):202–212
    Shefer G, Oron U, Irintchev A, Werning A, Halevy O (2001) Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway. J Cell Physiol 187(1):73–80
    Campana V, Moya M, Gavotto A, Simes JC, Spitale L, Soriano F (2003) He–Ne laser on microcrystalline arthropathies. J Clin Laser Med Surg 21(2):99–103
    Bjordal J, Couppé C, Ljunggreen A (2001) A literature review of possible effective intervals of red and infrared irradiation for enhanced tissue repair in the locomotor system. In: “Abstract Book, 9th Congress of European Society for Photobiology”, p 190
    Giuliani A, Fernandez M, Farinelli M, Baratto L, Capra R, Rovetta G (2004) Very low level laser therapy attenuates edema and pain in experimental models. Int J Tissue React 26(1–2):29–37
    Karu T, Pyatribat LV, Ryabykh T (1997) Nonmonotonic behaviour of the dose dependence of the radiation effect on cells in vitro exposed to pulsed laser radiation at 820 nm wavelength. Lasers Surg Med 21:485–492
    Halse R, Pearson SL, McCormack J, Yeaman SJ, Taylor R (2001) Effects of tumor necrosis factor-α on insulin action in cultured human muscle cells. Diabetes 50:1102–1109
    Krause KM, Moody MR, Andrade FH, Taylor AA, Miller CC, Lester K, Reid MB (1998) Peritonitis cause diaphragm weakness in rats. Am J Respir Crit Care Med 157:1277–1282
    Goubel F, Pigot A, Allaf O, Verleye M, Gillardin JM (1995) Endotoxins modify muscle fatigue characteristics. Fundam Clin Pharmacol 9(2):202–204
    Anderson JL, Williams G, Head SI (2001) The role of nitric oxide in diaphragmatic dysfunction in endotoxemic rats. Muscle Nerve 24(1):30–36
    Goldman JA (1981) Investigative studies of laser technology in rheumatology and immunology. Biomedical laser technology clinical applications. Springer, Berlin Heidelberg New York
    Basford JR (1995) Low intensity laser therapy: still not an established clinical tool. Lasers Surg Med 16(4):331–342
    Beckerman H, de Bie RA, Bouter LM, de Cuyper HJ, Oostendorp RA (1992) The efficacy of laser therapy for musculoskeletal and skin disorders: a criteria-based meta-analysis of randomized clinical trials. Phys Ther 72(7):483–491
    Bibikova A, Oron U (1993) Promotion of muscle regeneration in the toad (Bufo viridis) gastrocnemius muscle by low-energy laser irradiation. Anat Rec 235(3):374–380
    Amaral AC, Parizotto NA, Salvini TF (2001) Dose-dependency of low-energy HeNe laser effect in regeneration of skeletal muscle in mice. Lasers Med Sci 16(1):44–51
    Goluszko E, Deng C, Poussin A, Christadoss P (2002) Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis. J Neuroimmunol 122:85–93
    Zhang GX, Navikas V, Link H (1997) Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 20:543–552
    Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE (2005) The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 34(6):819–836
    Brosseau L, Robinson V, Wells G, Debie R, Gam A, Harman K et al (2005) Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev 4:CD002049